BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27491943)

  • 1. Practices of partnership: Negotiated safety among couples who inject drugs.
    Rance J; Rhodes T; Fraser S; Bryant J; Treloar C
    Health (London); 2018 Jan; 22(1):3-19. PubMed ID: 27491943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention.
    Treloar C; Rance J; Bryant J; Fraser S
    Drug Alcohol Depend; 2016 Nov; 168():170-175. PubMed ID: 27665209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injecting practices in sexual partnerships: hepatitis C transmission potentials in a 'risk equivalence' framework.
    Harris M; Rhodes T
    Drug Alcohol Depend; 2013 Oct; 132(3):617-23. PubMed ID: 23664125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Don't think I'm going to leave you over it": Accounts of changing hepatitis C status among couples who inject drugs.
    Rance J; Treloar C; Fraser S; Bryant J; Rhodes T
    Drug Alcohol Depend; 2017 Apr; 173():78-84. PubMed ID: 28208098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More than just someone to inject drugs with: Injecting within primary injection partnerships.
    Morris MD; Bates A; Andrew E; Hahn J; Page K; Maher L
    Drug Alcohol Depend; 2015 Nov; 156():275-281. PubMed ID: 26460140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Affording' new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention.
    Fraser S; Treloar C; Gendera S; Rance J
    Int J Drug Policy; 2017 Dec; 50():19-35. PubMed ID: 28982041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; BarĂ³n A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.
    Morris MD; Evans J; Montgomery M; Yu M; Briceno A; Page K; Hahn JA
    PLoS One; 2014; 9(10):e109282. PubMed ID: 25286346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The missing mass of morality: a new fitpack design for hepatitis C prevention in sexual partnerships.
    Fraser S
    Int J Drug Policy; 2013 May; 24(3):212-9. PubMed ID: 23602226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative accounts of needle and syringe cleaning techniques among people who inject drugs in Sydney, Australia.
    Nathani J; Iversen J; Shying K; Byrne J; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):413-9. PubMed ID: 20636658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intimate relationship as a site of social protection: Partnerships between people who inject drugs.
    Rhodes T; Rance J; Fraser S; Treloar C
    Soc Sci Med; 2017 May; 180():125-134. PubMed ID: 28343111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.
    Rowe R; Berger I; Yaseen B; Copeland J
    Drug Alcohol Rev; 2017 Sep; 36(5):658-666. PubMed ID: 28244160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the prevalence of HCV amongst people who inject drugs: an investigation into the risks associated with injecting paraphernalia sharing.
    Corson S; Greenhalgh D; Taylor A; Palmateer N; Goldberg D; Hutchinson S
    Drug Alcohol Depend; 2013 Nov; 133(1):172-9. PubMed ID: 23791029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.
    Morris MD; Andrew E; Tan JY; Maher L; Hoff C; Darbes L; Page K
    PLoS One; 2019; 14(5):e0217811. PubMed ID: 31150518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining the healthy body: Blood management and hepatitis C prevention among men who inject performance and image-enhancing drugs.
    Fomiatti R; Lenton E; Latham JR; Fraser S; Moore D; Seear K; Aitken C
    Int J Drug Policy; 2020 Jan; 75():102592. PubMed ID: 31855731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
    Rhodes T; Davis M; Judd A
    Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
    Iversen J; Wand H; Gonnermann A; Maher L;
    Int J Drug Policy; 2010 Nov; 21(6):471-6. PubMed ID: 20472417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of boyfriends and intimate sexual partners in the initiation and maintenance of injecting drug use among women in coastal Kenya.
    Mburu G; Limmer M; Holland P
    Addict Behav; 2019 Jun; 93():20-28. PubMed ID: 30682678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.
    Harris M; Rhodes T
    Addiction; 2012 Jun; 107(6):1090-6. PubMed ID: 22151433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.